Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 101

1.

Expression characteristics of proteins of the insulin-like growth factor axis in non-small cell lung cancer patients with preexisting type 2 diabetes mellitus.

Ding J, Tang J, Chen X, Men HT, Luo WX, Du Y, Ge J, Li C, Chen Y, Cheng K, Qiu M, Liu JY.

Asian Pac J Cancer Prev. 2013;14(10):5675-80.

PMID:
24289561
[PubMed - in process]
Free Article
2.

Expressions of insulin-like growth factor receptor-1 and insulin-like growth factor binding protein 3 in advanced non-small-cell lung cancer.

Kim YH, Sumiyoshi S, Hashimoto S, Masago K, Togashi Y, Sakamori Y, Okuda C, Mio T, Mishima M.

Clin Lung Cancer. 2012 Sep;13(5):385-90. doi: 10.1016/j.cllc.2011.11.009. Epub 2012 Jan 28.

PMID:
22285568
[PubMed - indexed for MEDLINE]
3.

Molecular analysis of non-small cell lung cancer identifies subsets with different sensitivity to insulin-like growth factor I receptor inhibition.

Gualberto A, Dolled-Filhart M, Gustavson M, Christiansen J, Wang YF, Hixon ML, Reynolds J, McDonald S, Ang A, Rimm DL, Langer CJ, Blakely J, Garland L, Paz-Ares LG, Karp DD, Lee AV.

Clin Cancer Res. 2010 Sep 15;16(18):4654-65. doi: 10.1158/1078-0432.CCR-10-0089. Epub 2010 Jul 29.

PMID:
20670944
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

[Expression and significance of PTEN/PI3K signal transduction-related proteins in non-small cell lung cancer].

Liao DW, Wang L, Zhang XG, Liu MQ.

Ai Zheng. 2006 Oct;25(10):1238-42. Chinese.

PMID:
17059767
[PubMed - indexed for MEDLINE]
5.

Clinical significance of insulin receptor substrate-I down-regulation in non-small cell lung cancer.

Han CH, Cho JY, Moon JT, Kim HJ, Kim SK, Shin DH, Chang J, Ahn CM, Kim SK, Chang YS.

Oncol Rep. 2006 Dec;16(6):1205-10.

PMID:
17089038
[PubMed - indexed for MEDLINE]
6.

Clinical significance of immunohistochemical expression of insulin-like growth factor-1 receptor and matrix metalloproteinase-7 in resected non-small cell lung cancer.

Yamamoto T, Oshima T, Yoshihara K, Nishi T, Arai H, Inui K, Kaneko T, Nozawa A, Adachi H, Rino Y, Masuda M, Imada T.

Exp Ther Med. 2012 May;3(5):797-802. Epub 2012 Feb 22.

PMID:
22969971
[PubMed]
Free PMC Article
7.

Prognostic implications of tumoral expression of insulin like growth factors 1 and 2 in patients with non-small-cell lung cancer.

Kim JS, Kim ES, Liu D, Lee JJ, Solis L, Behrens C, Lippman SM, Hong WK, Wistuba II, Lee HY.

Clin Lung Cancer. 2014 May;15(3):213-21. doi: 10.1016/j.cllc.2013.12.006. Epub 2014 Jan 1.

PMID:
24485233
[PubMed - in process]
8.

Clinical significance of insulin-like growth factor-1 receptor expression in stage I non-small-cell lung cancer: immunohistochemical analysis.

Lee CY, Jeon JH, Kim HJ, Shin DH, Roh TW, Ahn CM, Chang YS.

Korean J Intern Med. 2008 Sep;23(3):116-20. doi: 10.3904/kjim.2008.23.3.116.

PMID:
18787363
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Central insulin and insulin-like growth factor-1 signaling: implications for diabetes associated dementia.

Zemva J, Schubert M.

Curr Diabetes Rev. 2011 Sep;7(5):356-66. Review.

PMID:
21916834
[PubMed - indexed for MEDLINE]
10.

The rationale and development of therapeutic insulin-like growth factor axis inhibition for lung and other cancers.

Camidge DR, Dziadziuszko R, Hirsch FR.

Clin Lung Cancer. 2009 Jul;10(4):262-72. doi: 10.3816/CLC.2009.n.037. Review.

PMID:
19632946
[PubMed - indexed for MEDLINE]
11.

Down-regulation of insulin-like growth factor-I receptor and insulin receptor substrate-1 expression in advanced human breast cancer.

Schnarr B, Strunz K, Ohsam J, Benner A, Wacker J, Mayer D.

Int J Cancer. 2000 Nov 20;89(6):506-13.

PMID:
11102895
[PubMed - indexed for MEDLINE]
12.

Insulin-like growth factor-1 (IGF-1) receptor-insulin receptor substrate complexes in the uterus. Altered signaling response to estradiol in the IGF-1(m/m) mouse.

Richards RG, Walker MP, Sebastian J, DiAugustine RP.

J Biol Chem. 1998 May 8;273(19):11962-9.

PMID:
9565625
[PubMed - indexed for MEDLINE]
Free Article
13.

Implication of the insulin-like growth factor-IR pathway in the resistance of non-small cell lung cancer cells to treatment with gefitinib.

Morgillo F, Kim WY, Kim ES, Ciardiello F, Hong WK, Lee HY.

Clin Cancer Res. 2007 May 1;13(9):2795-803.

PMID:
17473213
[PubMed - indexed for MEDLINE]
Free Article
14.

Role of insulin receptor substrates and protein kinase C-zeta in vascular permeability factor/vascular endothelial growth factor expression in pancreatic cancer cells.

Neid M, Datta K, Stephan S, Khanna I, Pal S, Shaw L, White M, Mukhopadhyay D.

J Biol Chem. 2004 Feb 6;279(6):3941-8. Epub 2003 Nov 6.

PMID:
14604996
[PubMed - indexed for MEDLINE]
Free Article
15.

[Variation of insulin receptor substrate-2 gene 3'-untranslated region in patients with type 2 diabetes mellitus].

Zeng WM, Chen SH, Xie P, Liu ML, Song HP.

Yi Chuan Xue Bao. 2003 Aug;30(8):785-9. Chinese.

PMID:
14682250
[PubMed - indexed for MEDLINE]
16.

mRNA expression of IGF-1 and IGF-1R in patients with colorectal adenocarcinoma and type 2 diabetes.

Liu R, Hu LL, Sun A, Cao YJ, Tang T, Zhang XP, Zhang QH.

Arch Med Res. 2014 May;45(4):318-24. doi: 10.1016/j.arcmed.2014.04.003. Epub 2014 Apr 18.

PMID:
24751329
[PubMed - in process]
17.

erbB3 recruitment of insulin receptor substrate 1 modulates insulin-like growth factor receptor signalling in oestrogen receptor-positive breast cancer cell lines.

Knowlden JM, Gee JM, Barrow D, Robertson JF, Ellis IO, Nicholson RI, Hutcheson IR.

Breast Cancer Res. 2011 Sep 22;13(5):R93. doi: 10.1186/bcr3018.

PMID:
21939528
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Insulin receptor substrates mediate distinct biological responses to insulin-like growth factor receptor activation in breast cancer cells.

Byron SA, Horwitz KB, Richer JK, Lange CA, Zhang X, Yee D.

Br J Cancer. 2006 Nov 6;95(9):1220-8. Epub 2006 Oct 17.

PMID:
17043687
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Increased insulin sensitivity in IGF-I receptor--deficient brown adipocytes.

Mur C, Valverde AM, Kahn CR, Benito M.

Diabetes. 2002 Mar;51(3):743-54.

PMID:
11872675
[PubMed - indexed for MEDLINE]
Free Article
20.

Tamoxifen interferes with the insulin-like growth factor I receptor (IGF-IR) signaling pathway in breast cancer cells.

Guvakova MA, Surmacz E.

Cancer Res. 1997 Jul 1;57(13):2606-10.

PMID:
9205064
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk